Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 13, 2026
Reporting period
Not applicable
Filed with the SEC
May 15, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001420501-26-000004
Filed / recorded
May 15, 2026, 8:15 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Elevance Health, Inc.
Issuer CIK
1156039
Ticker
ELV
Reporting person
Ryan M. Schneider
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 13, 2026
Transaction code
A
Shares / units
563
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
7,163
Ownership form
Direct
Amendment
No
Footnotes from the filing
Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.